Route

Virginia Cancer Specialists Continues to Increase Access to Care in New, Expanded Fair Oaks, VA, Location, Now Open

Retrieved on: 
Thursday, May 2, 2024
Brain, Cancer, Genetics, Palliative care, Blood, Fairfax County Parkway, Suite, I-66, Elective surgery, Estate (law), Breast, Oncology, Research, FACS, Patient, Physician, Lung, Route, Social, Diagnosis, Radiation, Quality of life, Hematology, Genetic counseling, Breast cancer, Nursing

FAIRFAX, Va., May 2, 2024 /PRNewswire/ -- Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia, reinforces its commitment to providing exceptional cancer care and progressing clinical cancer research by expanding its third location in the last 6 months. Virginia Cancer Specialists serves patients in 10 locations throughout Northern Virginia with advanced, integrated, complete cancer care.

Key Points: 
  • Now in its 52nd year, Virginia Cancer Specialists continues to increase service and access to quality cancer care throughout Northern Virginia.
  • FAIRFAX, Va., May 2, 2024 /PRNewswire/ -- Virginia Cancer Specialists, the largest private cancer practice in Northern Virginia, reinforces its commitment to providing exceptional cancer care and progressing clinical cancer research by expanding its third location in the last 6 months.
  • Virginia Cancer Specialists serves patients in 10 locations throughout Northern Virginia with advanced, integrated, complete cancer care.
  • Founded in 1972, Virginia Cancer Specialists has been an integral part of the Northern Virginia medical community for over 50 years.

The Transat CIC Started Yesterday: Alberto Bona and the Class40 IBSA in Fourth Position After 24 Hours of Navigation

Retrieved on: 
Monday, April 29, 2024
Pharmaceutical, Sailing, Health, Sports, Transat Jacques Vabre, Pain, Courage, BOAT, Inflammation, Weather, Panerai, Transat, Solitaire, IBSA, ARC, Disability, Partnership, Endocrinology, Maserati, Atlantic Ocean, Water, Quality, Dermatology, Wind, Figaro, Future, ULDB, Face, CHF, IMOCA, La, Route, Gruppo TIM, Philosophy, Reproductive medicine, Shipbuilding

It was a conservative start for Alberto Bona on the Class40 IBSA, at his eighth regatta with the Swiss multinational pharmaceutical company.

Key Points: 
  • It was a conservative start for Alberto Bona on the Class40 IBSA, at his eighth regatta with the Swiss multinational pharmaceutical company.
  • The wind was found just before dawn today, when the first disturbance brushed the Class40s: Finally, the boats started running.
  • The best a solitary navigator could wish for.”
    Giorgio Pisani, Vice President IBSA Group and leader of the project Sailing into the Future.
  • In 2023, Bona and the Class40 IBSA participated in six regattas, including the Rolex Fastnet Race and the Transat Jacques Vabre.

The Transat CIC Started Yesterday: Alberto Bona and the Class40 IBSA in Fourth Position After 24 Hours of Navigation

Retrieved on: 
Monday, April 29, 2024
Sailing, Health, Sports, Other Sports, General Sports, Pharmaceutical, Transat Jacques Vabre, Pain, Courage, BOAT, Inflammation, Weather, Panerai, Transat, Solitaire, IBSA, ARC, Disability, Partnership, Endocrinology, Maserati, Atlantic Ocean, Water, Quality, Dermatology, Wind, Figaro, Future, ULDB, Face, CHF, Multimedia, IMOCA, La, Route, Gruppo TIM, Philosophy, Reproductive medicine, Shipbuilding

A conservative start for Alberto Bona on the Class40 IBSA, at his eighth regatta with the Swiss multinational pharmaceutical company.

Key Points: 
  • A conservative start for Alberto Bona on the Class40 IBSA, at his eighth regatta with the Swiss multinational pharmaceutical company.
  • The wind was found just before dawn today, when the first disturbance brushed the Class40s: finally the boats started running.
  • The best a solitary navigator could wish for.”
    Giorgio Pisani, Vice President IBSA Group and leader of the project Sailing into the Future.
  • In 2023, Bona and the Class40 IBSA participated in six regattas, including the Rolex Fastnet Race and the Transat Jacques Vabre.

Transat CIC, Three Days to the Start for the Class40 IBSA

Retrieved on: 
Thursday, April 25, 2024
Pharmaceutical, Sailing, Health, Sports, Transat Jacques Vabre, Class40, Pain, Courage, BOAT, Inflammation, Panerai, Transat, Solitaire, IBSA, ARC, Safety, Disability, Partnership, Endocrinology, Dermatology, Maserati, Atlantic Ocean, Water, Quality, Risk, Figaro, Future, ULDB, Face, CHF, Route, Temperature, Gruppo TIM, Running, Philosophy, Reproductive medicine, Shipbuilding

Three days before the start, scheduled for 1:02 p.m. on Sunday, April 28, the third season of the project Sailing into the Future.

Key Points: 
  • Three days before the start, scheduled for 1:02 p.m. on Sunday, April 28, the third season of the project Sailing into the Future.
  • Together, sponsored by IBSA, gets underway with a test that is already set to become epic, due to the many difficulties to overcome.
  • “We are ready for this new undertaking of the Class40 IBSA,” declared Giorgio Pisani, Vice President IBSA Group and Leader of the project Sailing into the Future.
  • In 2023, Bona and the Class40 IBSA participated in six regattas, including the Rolex Fastnet Race and the Transat Jacques Vabre.

U.S. Virgin Islands Excels at Routes Americas, Achieving Record Air Access and Strong Growth

Retrieved on: 
Wednesday, March 27, 2024
USVI, Growth, STT, STX, Travel, JetBlue, Route, Contiguous United States, Marketing, Airline

ST. THOMAS, U.S. Virgin Islands, March 27, 2024 /PRNewswire/ -- The U.S. Virgin Islands (USVI) emerged as a standout presence at Routes Americas, held in Bogota, Colombia from March 19th to 21st.

Key Points: 
  • ST. THOMAS, U.S. Virgin Islands, March 27, 2024 /PRNewswire/ -- The U.S. Virgin Islands (USVI) emerged as a standout presence at Routes Americas, held in Bogota, Colombia from March 19th to 21st.
  • Led by Commissioner Joseph Boschulte of the U.S. Virgin Islands Department of Tourism (DTO), the USVI delegation exemplified strategic prowess in advancing air access and fostering crucial partnerships within the aviation industry.
  • "Our participation at Routes Americas 2024 was instrumental in solidifying our partnerships with key airlines and furthering our efforts to enhance air access to the U.S. Virgin Islands.
  • The U.S. Virgin Islands Department of Tourism remains dedicated to building upon the momentum gained at Routes Americas 2024.

Embrace Home Loans Opens Two New Offices in Rhode Island

Retrieved on: 
Friday, March 15, 2024
Laprade, Embrace Home Loans, Growth, Real estate agent, Route, SVP, Record, Quality of life, Raffa, Housing, Investment, ChatGPT

 MIDDLETOWN, R.I. , March 15, 2024 /PRNewswire/ -- Embrace Home Loans, a top-ranked national mortgage lender, recently expanded its reach in Rhode Island by opened offices in East Greenwich and East Providence. Branch Manager Mike Raffa leads the East Greenwich office and Branch Manager Jared Maxwell leads the East Providence office. Both previously served in Embrace's Middletown, Rhode Island branch office.

Key Points: 
  • MIDDLETOWN, R.I. , March 15, 2024 /PRNewswire/ -- Embrace Home Loans , a top-ranked national mortgage lender, recently expanded its reach in Rhode Island by opened offices in East Greenwich and East Providence.
  • Both previously served in Embrace's Middletown, Rhode Island branch office.
  • "We are delighted to grow our presence in Rhode Island," said Paul Laprade, SVP, regional executive with Embrace.
  • Our branch is uniquely positioned to reach the widest range of homebuyers throughout Rhode Island and Southeastern Massachusetts."

Toll Brothers Announces New Luxury Home Community Coming Soon to the Florida Panhandle

Retrieved on: 
Tuesday, February 27, 2024
CITY, Architecture, Toll Brothers, Breakwater, Route, Tennis, Design studio, Consultant, Pier Park, Gulf of Mexico, Salient (geography), Water

PANAMA CITY BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Breakwater , is coming soon to the Panhandle of Florida.

Key Points: 
  • PANAMA CITY BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Breakwater , is coming soon to the Panhandle of Florida.
  • Construction of the Toll Brothers Sales Center and model homes will begin this spring, and sales will start in late summer of 2024.
  • Breakwater is an exclusive, gated community featuring Toll Brothers’ award-winning coastal architecture situated on beautiful home sites, many with preserve or water views.
  • For more information on Breakwater and Toll Brothers communities throughout Florida, call (877) 958-1140 or visit TollBrothers.com/Florida .

Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial

Retrieved on: 
Wednesday, February 21, 2024
SAN, Medicine, Ambient occlusion, Randomized controlled trial, Catheter, MD, Principal, FDA, Route, Reperfusion, Safety, Radiology, Patient, Anatomy, Neurosurgery, RCT, DRS, MAX, Brain, Pharmaceutical industry

SAN MATEO, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the completion of enrollment in its 250-patient SUMMIT MAX clinical trial ( NCT05018650 ) evaluating the safety and effectiveness of its HiPoint™ 88 and HiPoint 70 Reperfusion Catheters as part of the MonopointⓇ Reperfusion System.

Key Points: 
  • SAN MATEO, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the completion of enrollment in its 250-patient SUMMIT MAX clinical trial ( NCT05018650 ) evaluating the safety and effectiveness of its HiPoint™ 88 and HiPoint 70 Reperfusion Catheters as part of the MonopointⓇ Reperfusion System.
  • SUMMIT MAX is the first FDA-approved aspiration thrombectomy trial which is randomized.
  • Randomized controlled trials provide the best clinical science and the SUMMIT MAX Trial compares the Route 92 Medical Monopoint System to the largest commercially available conventional aspiration system.
  • “Route 92 Medical is leading the way in neurovascular innovation technology, bringing clinicians complete solutions designed to improve endovascular thrombectomy procedure times and outcomes.

Global Anterior Uveitis (Iritis) Drug Pipeline Research Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 6, 2024
Health, Other Science, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Therapy, Acquisition, IOP, Macrophage, News, Route, Eye, Uveitis, Discovery, Risk, Administration, Clinical trial, Immunomodulation, NDA, NCE, Pharmaceutical industry

This report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anterior Uveitis pipeline landscape.

Key Points: 
  • This report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Anterior Uveitis pipeline landscape.
  • A detailed picture of the Anterior Uveitis pipeline landscape is provided which includes the disease overview and Anterior Uveitis treatment guidelines.
  • The assessment part of the report embraces, in depth Anterior Uveitis commercial assessment and clinical assessment of the pipeline products under development.
  • Anterior Uveitis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.

Global Psoriatic Arthritis Drug Landscape Research Report 2024: Comprehensive Insights About 20+ Companies and 25+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 6, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Therapy, Acquisition, Arthritis, Psoriasis, Psoriatic arthritis, TEM, Inflammation, Malignancy, News, Atopic dermatitis, Route, Phase II, JAK1, KCNA3, JAK3, Discovery, Cell, Bristol Myers Squibb, Multiple sclerosis, Administration, Cytokine, Rheumatoid arthritis, TYK2, Clinical trial, NDA, Lluís Companys, Immune system, JAK2, Pharmaceutical industry

This report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape.

Key Points: 
  • This report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Psoriatic Arthritis pipeline landscape.
  • A detailed picture of the Psoriatic Arthritis pipeline landscape is provided which includes the disease overview and Psoriatic Arthritis treatment guidelines.
  • The assessment part of the report embraces, in depth Psoriatic Arthritis commercial assessment and clinical assessment of the pipeline products under development.
  • Psoriatic Arthritis pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.